cystic fibrosis gene therapy (Genzyme)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecystic fibrosis gene therapy (Genzyme)
Drug Alias NameCFTR-GT (Genzyme)GL-53:DOPE (Genzyme)GL-67:DOPE (Genzyme)CFTR-GT
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Heart & Lung InstituteGenzyme Corp
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A